Clinical Trials in Salt Lake City

Showing 3661-3680 of 11,982 trials

Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

NCT03533517

This is a non-randomized, prospective, multi-center Early Feasibility Study to evaluate the AccuCinch® Ventricular Restoration System in Patients with Heart Failure and Reduced Ejection Fraction (HFrEF).

Heart FailureCardiomyopathy, Dilated

Ancora Heart, Inc.22 participantsStarted Aug 2018

San Francisco, California, United States • Atlanta, Georgia, United States • Louisville, Kentucky, United States +15 more locations

COMPLETEDNA< 1 mile

The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

NCT02806570

This is a multi-center, non-randomized, prospective Early Feasibility Study to evaluate the AccuCinch® Ventricular Restoration System in patients with symptomatic heart failure and concomitant functional mitral regurgitation that have stable symptoms on guideline-directed medical therapy

Heart FailureMitral Valve InsufficiencyCardiomyopathies

Ancora Heart, Inc.35 participantsStarted Aug 2016

Atlanta, Georgia, United States • Louisville, Kentucky, United States • Minneapolis, Minnesota, United States +13 more locations

Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

Find Trials by Condition in Salt Lake City

Islatravir and Methadone Pharmacokinetics (MK-8591-029)

Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

The PROMISE Study: Duavee in Women With DCIS

B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis

The INSPIRE-ASP PNA Trial

Coordinated, Collaborative, Comprehensive, Family-based, Integrated, Technology-enabled Stroke Care

Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer

Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies

A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL)

Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium

Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.

A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors

Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer

PerQseal® Clinical Study

FemBloc® Permanent Contraception - Confirmation Feasibility Trial

A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers

RGX-121 Gene Therapy in Children 5 Years of Age and Over With MPS II (Hunter Syndrome)

Plasma Resuscitation Without Lung Injury